ARCHIVES

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

This article is from The Cancer Letter archive.

Vol. 34 No. 29 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

TGen’s Trent To Lead Van Andel Institute

February 13, 2009

Congress Nearing Final Action On Appropriations, But Potential GRH Cuts Leaves Outlook Unclear

September 12, 1986

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013

Vanderbilt Recruits Sosman To Lead Tumor Immunology.

January 18, 2002

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977